EUVIMED · CrossrefJournal
Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 · OAE Publishing Inc.
Latest articles
Current advances in homozygous familial hypercholesterolemia management
Clinical translation of findings from rare disease animal models to veterinary patients: practical reality or elusive dream
Disappointment and/or a glimmer of hope? - When biochemical efficacy does not translate into (primary) clinical benefit
Beyond copper retention: a dynamic flux-compartment-response model of Wilson disease
Transcriptional adaptation opens new therapeutic possibilities for Duchenne muscular dystrophy and rare neuromuscular diseases
Advances in the application of deep learning in computed tomography imaging analysis of rare lung diseases
Immunotherapeutic advances for the treatment of osteosarcoma, driven by studies in pet dogs with spontaneous disease
Computational modelling of cerebrospinal fluid flow in a translational canine model
Diagnosis and therapy of Niemann-Pick disease type C1- what have we learned that can help veterinary patients?
Primary sclerosing encapsulating peritonitis with cryptorchidism in an older man: case report and literature review
Complex LDLR mutations in Taiwanese familial hypercholesterolemia
From ebola to feline infectious peritonitis: the cross-species journey of GS-441524 and the future of antiviral translation
Rare pituitary diseases in dogs and cats and their human companions
Pediatric mesenteric lymphangioma leading to extensive small bowel torsion and transplant rescue: a case report
Rare disease preparedness: the time is now
Concerns for inclusive comprehensive neurofibromatosis care - looking at the LGBTQ+ community
Gut microbial dysbiosis in Gaucher disease: implications for associated complications
Phenotypic delineation of SET-related neurodevelopmental disorder: two case reports and literature review
Applications and prospects of machine learning in the diagnosis and treatment of SLE
Stem cell therapy for rare neurological diseases: translational research opportunities
Commentary on: ribozyme-activated RNA trans-ligation: an emerging strategy for large gene delivery in muscular dystrophies
Commentary on gait analysis in Duchenne muscular dystrophy: integrating contracture, strength, and kinematic perspectives
The critical importance of recognizing Gaucher disease in the fifth decade and beyond
Adeno-associated viral vector gene therapy for canine hemophilia
Plexiform neurofibromas in neurofibromatosis type 1: current and emergent therapeutic strategies
Gene therapy for inborn errors of immunity: past progress, current status and future directions
From hype to hope: foundational requirements for NF1 gene therapy success
Potential barriers to reverse cascade screening combined with universal cholesterol screening for paediatric familial hypercholesterolemia: focus on second-degree relatives of a proband
First, do no harm: the role of preclinical animal models in predicting adverse events in gene therapy clinical trials for Duchenne muscular dystrophy and X-Linked myotubular myopathy
Patient organizations: advocating for timely newborn screening & improved quality of life
EUVIMED